Pfizer Didn’t Breach Antitrust Laws: Indonesian Court

Law360, San Diego (September 8, 2011, 3:23 PM EDT) -- An Indonesian court on Wednesday reportedly ruled that Pfizer Inc. and four subsidiaries did not violate anti-monopoly statutes, overturning rulings by the country's antitrust watchdog that it had abused its dominant position in the market for anti-hypertensive drugs by overcharging consumers.

The Central Jakarta District Court determined that there was not enough evidence to support the rulings by the antitrust agency, KPPU, and reversed the orders against Pfizer, its units and Indonesian drug company Dexa Medica, according to a Dow Jones news report.

A lawyer representing...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.